source
- FDA says former officials' journal articles do not represent agency policy after lawmaker criticismActing FDA director Kyle Diamantas wrote to House Energy & Commerce ranking member Diana DeGette, stating that journal papers authored by former agency officials do not convey FDA policy or regulat…
- Eli Lilly to buy psychedelics biotech AtaiBeckley for $2.8 billion, adding late-stage depression drugEli Lilly announced it will acquire New York‑based biotech AtaiBeckley in a transaction valued at about $2.8 billion. The agreement sets the purchase price at $6.75 per share, a 26 % premium to At…